116 related articles for article (PubMed ID: 37513918)
1. Stimulation of Autophagy by Dapagliflozin Mitigates Cadmium-Induced Testicular Dysfunction in Rats: The Role of AMPK/mTOR and SIRT1/Nrf2/HO-1 Pathways.
Arab HH; Fikry EM; Alsufyani SE; Ashour AM; El-Sheikh AAK; Darwish HW; Al-Hossaini AM; Saad MA; Al-Shorbagy MY; Eid AH
Pharmaceuticals (Basel); 2023 Jul; 16(7):. PubMed ID: 37513918
[TBL] [Abstract][Full Text] [Related]
2. Thymoquinone effects on autophagy, apoptosis, and oxidative stress in cisplatin-induced testicular damage in mice.
Shojaedini M; Hemadi M; Saki G; Fakhredini F; Khodayar MJ; Khorsandi L
J Assist Reprod Genet; 2024 Apr; ():. PubMed ID: 38568464
[TBL] [Abstract][Full Text] [Related]
3. Anthocyanins from
Dong M; Lu J; Xue H; Lou Y; Li S; Liu T; Ding Z; Chen X
Pharmaceuticals (Basel); 2024 Mar; 17(3):. PubMed ID: 38543108
[TBL] [Abstract][Full Text] [Related]
4. Dapagliflozin prevents oxidative stress-induced endothelial dysfunction via sirtuin 1 activation.
Zhou Y; Tai S; Zhang N; Fu L; Wang Y
Biomed Pharmacother; 2023 Sep; 165():115213. PubMed ID: 37517289
[TBL] [Abstract][Full Text] [Related]
5. Role of hypoxia inducible factor/vascular endothelial growth factor/endothelial nitric oxide synthase signaling pathway in mediating the cardioprotective effect of dapagliflozin in cyclophosphamide-induced cardiotoxicity.
Mahmoud Refaie MM; Bayoumi AM; Mokhemer SA; Shehata S; Abd El-Hameed NM
Hum Exp Toxicol; 2023; 42():9603271231193392. PubMed ID: 37526264
[TBL] [Abstract][Full Text] [Related]
6. Pancreatitis in a 57-Year-Old Female Two Weeks After Initiation of Empagliflozin.
Poloju A; Majety P; Groysman A
AACE Clin Case Rep; 2023; 9(4):104-107. PubMed ID: 37520757
[TBL] [Abstract][Full Text] [Related]
7. Dapagliflozin-affected endothelial dysfunction and altered gut microbiota in mice with heart failure.
Bao N; Liu X; Zhong X; Jia S; Hua N; Zhang L; Mo G
PeerJ; 2023; 11():e15589. PubMed ID: 37520255
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Pregabalin and Duloxetine in Patients with Painful Diabetic Peripheral Neuropathy (PDPN): A Multi-Centre Phase IV Clinical Trial-BLOSSOM.
Rakusa M; Marolt I; Stevic Z; Rebrina SV; Milenkovic T; Stepien A
Pharmaceuticals (Basel); 2023 Jul; 16(7):. PubMed ID: 37513930
[TBL] [Abstract][Full Text] [Related]
9. Characterization of hepatotoxic effects induced by pyraclostrobin in human HepG2 cells and zebrafish larvae.
Wu M; Bian J; Han S; Zhang C; Xu W; Tao L; Li Z; Zhang Y
Chemosphere; 2023 Nov; 340():139732. PubMed ID: 37549743
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of genitourinary infection in diabetic patients treated with SGLT 2 inhibitors.
Shrikrishna A; Archana B
Afr Health Sci; 2023 Mar; 23(1):270-275. PubMed ID: 37545909
[TBL] [Abstract][Full Text] [Related]
11. The Impact of SGLT2 Inhibitors on Cardiovascular Outcomes in Patients With Heart Failure With Preserved Ejection Fraction.
Starr JA; Pinner NA
Ann Pharmacother; 2024 May; 58(5):506-513. PubMed ID: 37542422
[TBL] [Abstract][Full Text] [Related]
12. [Indicators of diabetes mellitus after liraglutide, sitagliptin/metformin, linagliptin, and sitagliptin].
Atonal-Flores B; León-Vázquez ML; Barranco-Juarez A
Rev Med Inst Mex Seguro Soc; 2023 Jul; 61(4):489-495. PubMed ID: 37540652
[TBL] [Abstract][Full Text] [Related]
13. [SGLT2-inhibitors (gliflozins) - multipurpose medications and the statins of the 21st century?].
Zeeh J
MMW Fortschr Med; 2023 Aug; 165(14):46-48. PubMed ID: 37537462
[No Abstract] [Full Text] [Related]
14. Cardiac and Metabolic Effects of Dapagliflozin in Heart Failure With Preserved Ejection Fraction: The CAMEO-DAPA Trial.
Borlaug BA; Reddy YNV; Braun A; Sorimachi H; Omar M; Popovic D; Alogna A; Jensen MD; Carter R
Circulation; 2023 Sep; 148(10):834-844. PubMed ID: 37534453
[TBL] [Abstract][Full Text] [Related]
15. EMPA-KIDNEY: expanding the range of kidney protection by SGLT2 inhibitors.
Fernández-Fernandez B; Sarafidis P; Soler MJ; Ortiz A
Clin Kidney J; 2023 Aug; 16(8):1187-1198. PubMed ID: 37529652
[TBL] [Abstract][Full Text] [Related]
16. Emphysematous Kidney Related to the Use of Empagliflozin in a Diabetic Woman.
Echeverria P; Saa J; Paz Y Miño LD
AACE Clin Case Rep; 2023; 9(4):136-139. PubMed ID: 37520756
[TBL] [Abstract][Full Text] [Related]
17. Drugs for anxiety disorders.
Med Lett Drugs Ther; 2023 Aug; 65(1682):121-128. PubMed ID: 37516898
[No Abstract] [Full Text] [Related]
18. Enhancement of biochemical and genomic pathways through lycopene-loaded nano-liposomes: Alleviating insulin resistance, hepatic steatosis, and autophagy in obese rats with non-alcoholic fatty liver disease: Involvement of SMO, GLI-1, and PTCH-1 genes.
Salem GA; Mohamed AA; Khater SI; Noreldin AE; Alosaimi M; Alansari WS; Shamlan G; Eskandrani AA; Awad MM; El-Shaer RAA; Nassan MA; Mostafa M; Khamis T
Gene; 2023 Oct; 883():147670. PubMed ID: 37516284
[TBL] [Abstract][Full Text] [Related]
19. Cost-Effectiveness of Newer Antidiabetic Drugs as Second-Line Treatment for Type 2 Diabetes: A Systematic Review.
Zhu J; Zhou Y; Li Q; Wang G
Adv Ther; 2023 Oct; 40(10):4216-4235. PubMed ID: 37515713
[TBL] [Abstract][Full Text] [Related]
20. The Effect of Additional Treatment with Empagliflozin or Semaglutide on Endothelial Function and Arterial Stiffness in Subjects with Type 1 Diabetes Mellitus-ENDIS Study.
Navodnik MP; Janež A; Žuran I
Pharmaceutics; 2023 Jul; 15(7):. PubMed ID: 37514131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
